Core Laboratories NV (NYSE:CLB) — Market Cap & Net Worth
Market Cap & Net Worth: Core Laboratories NV (CLB)
Core Laboratories NV (NYSE:CLB) has a market capitalization of $561.92 Million ($561.92 Million) as of June 17, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #11832 globally and #2940 in its home market, demonstrating a -9.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Core Laboratories NV's stock price $12.19 by its total outstanding shares 46096682 (46.10 Million). Review Core Laboratories NV debt and liabilities to assess the company's total debt and financial obligations.
Core Laboratories NV Market Cap History: 2015 to 2026
Core Laboratories NV's market capitalization history from 2015 to 2026. Data shows change from $4.47 Billion to $561.92 Million (-17.89% CAGR).
Index Memberships
Core Laboratories NV is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.05% | #541 of 602 |
Weight: Core Laboratories NV's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Core Laboratories NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Core Laboratories NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.40x
Core Laboratories NV's market cap is 1.40 times its annual revenue
Latest Price to Earnings (P/E) Ratio
24.91x
Core Laboratories NV's market cap is 24.91 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.04 Billion | $594.74 Million | $63.90 Million | 8.47x | 78.81x |
| 2017 | $4.69 Billion | $659.81 Million | $83.12 Million | 7.11x | 56.45x |
| 2018 | $2.60 Billion | $700.85 Million | $79.53 Million | 3.72x | 32.75x |
| 2019 | $1.71 Billion | $668.21 Million | $101.98 Million | 2.56x | 16.77x |
| 2020 | $1.21 Billion | $487.27 Million | -$97.64 Million | 2.49x | N/A |
| 2021 | $1.02 Billion | $470.25 Million | $19.73 Million | 2.17x | 51.82x |
| 2022 | $930.59 Million | $489.74 Million | $19.45 Million | 1.90x | 47.84x |
| 2023 | $812.19 Million | $509.79 Million | $36.67 Million | 1.59x | 22.15x |
| 2024 | $797.93 Million | $523.85 Million | $31.40 Million | 1.52x | 25.41x |
| 2025 | $738.93 Million | $526.52 Million | $29.67 Million | 1.40x | 24.91x |
Competitor Companies of CLB by Market Capitalization
Companies near Core Laboratories NV in the global market cap rankings as of June 17, 2026.
Key companies related to Core Laboratories NV by market ranking:
- Schlumberger NV (NYSE:SLB): Ranked #334 globally with a market cap of $79.34 Billion USD.
- Baker Hughes Co (NASDAQ:BKR): Ranked #452 globally with a market cap of $61.03 Billion USD.
- Halliburton Company (NYSE:HAL): Ranked #869 globally with a market cap of $31.08 Billion USD.
- TechnipFMC PLC (NYSE:FTI): Ranked #1012 globally with a market cap of $26.71 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #334 | Schlumberger NV | NYSE:SLB | $79.34 Billion | $53.07 |
| #452 | Baker Hughes Co | NASDAQ:BKR | $61.03 Billion | $61.52 |
| #869 | Halliburton Company | NYSE:HAL | $31.08 Billion | $37.20 |
| #1012 | TechnipFMC PLC | NYSE:FTI | $26.71 Billion | $67.00 |
Core Laboratories NV Historical Marketcap From 2015 to 2026
Between 2015 and today, Core Laboratories NV's market cap moved from $4.47 Billion to $ 561.92 Million, with a yearly change of -17.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $561.92 Million | -23.96% |
| 2025 | $738.93 Million | -7.39% |
| 2024 | $797.93 Million | -1.76% |
| 2023 | $812.19 Million | -12.72% |
| 2022 | $930.59 Million | -8.97% |
| 2021 | $1.02 Billion | -15.73% |
| 2020 | $1.21 Billion | -29.05% |
| 2019 | $1.71 Billion | -34.35% |
| 2018 | $2.60 Billion | -44.49% |
| 2017 | $4.69 Billion | -6.83% |
| 2016 | $5.04 Billion | +12.57% |
| 2015 | $4.47 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Core Laboratories NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $561.92 Million USD |
| MoneyControl | $561.92 Million USD |
| MarketWatch | $561.92 Million USD |
| marketcap.company | $561.92 Million USD |
| Reuters | $561.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Core Laboratories NV
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and … Read more